這兩個結果如何比較？死亡千人中，兩針接種人竟然占16%，而另一個對照試驗表明，未接種人群中，感染的人數也不過3.9%。

來源: greennew 於 2021-03-05 20:54:31 [檔案] [舊帖] [給我悄悄話] 本文已被閱讀：次 (12835 bytes)

回答: 如果是這樣，這些大量數據顯示的結果比原來發布的90%以上的保護率可是差多了吧？兩針後的死亡率16%，由 greennew 於 2021-03-05 20:25:26

這個60萬對52萬人的對照試驗結果：60萬疫苗組中共有608人感染，占0.1%。

樓主的這個報告卻發現2月死亡的近千人中，有150位已經接種了兩針。占總死亡人數的16%。

對照組，52萬未接種疫苗的感染人數為：20621，占3.9%。

這兩個結果如何比較？死亡千人中，兩針接種人竟然占16%，而未接種人群中，感染的人數也不過3.9%。

---------------------------------------------

60萬2千接種了2針輝瑞疫苗的人群中，僅21人住院治療，其中7人患重症，都超過50歲，半數以上有慢性病等基礎健康問題，3人中度症狀，11人為輕症。共有608人感染病毒，占0.1%。608位測試陽性的人，35%是因為出現症狀，65%是可能與感染者有接觸。

52萬8千人未接種疫苗的對照組中，有20,621人感染，將近4%，大約是接種疫苗組的40倍的陽性感染率。

11 min ago

Pfizer vaccine is about 95% effective against Covid-19, Israeli data shows?

From CNN's Amir Tal and Elizabeth Cohen

Data from more than 600,000 vaccinated Israelis shows the Pfizer vaccine is 95% effective, with only 21 vaccinated people ending up in the hospital with Covid-19, according to a press release from Maccabi Healthcare Services, Israel’s second largest healthcare provider.

The findings, while preliminary, suggest the vaccine remains remarkably effective in the real world and not just in the clinical trials conducted last year by Pfizer and BioNTech.

Maccabi looked at data from about 602,000 of its members who were at least one week past their second dose of the vaccine. Among them, 7 were hospitalized with severe symptoms, 3 with moderate symptoms, and 11 with mild symptoms.

All of the hospitalized members were over age 50, and half of them had a chronic health condition, such as morbid obesity, according to Ido Hadari, a Maccabi spokesman.

Among the 602,000 vaccinated members, tests showed that 608 became infected with Covid-19. Maccabi did not routinely test members, but of the 608, 35% chose to get tested because they had symptoms of Covid-19 and 65% chose to get tested because they had been exposed to someone with the virus.

Maccabi compared that infection rate with a group of 528,000 members who had not yet received the vaccine. In this control group, 20,621 people, or nearly 4%, were identified as having Covid-19.

Maccabi’s findings are similar to data released earlier this week by Israel’s largest healthcare provider, which found the vaccine was 94% effective. Pfizer’s clinical trial showed about the same efficacy.